Compositions and methods for the treatment of gastrointestinal polyps
AssigneeCellix Bio Private Limited
InventorMahesh Kandula
Life of this patent
Estimating the term…
Abstract
The disclosures herein provide compounds of formula I, formula II, formula III, formula IV, formula V and formula VI or its pharmaceutical acceptable salts, as well as polymorphs, enantiomers, stereoisomers, solvates, and hydrates thereof. These salts may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, lozenge, spray, intravenous, oral solution, buccal mucosal layer tablet, parenteral administration, syrup, or injection. Such compositions may be used to treatment of gastrointestinal polyps or its associated complications.
Claims9
A compound of Formula I:
- and pharmaceutically acceptable salts, hydrates, solvates, prodrugs, enantiomers, and stereoisomers thereof;
- wherein
- R1, R3, and R5 each independently represents NULL,
- R2, and R4 each independently represents
- n is independently 1, 2, 3, 4 or 5;
- a is independently 2, 3 or 7;
- each b is independently 3, 5 or 6;
- e is independently 1, 2 or 6;
- c and d are each independently H, D, —OH, —OD, C1-C6-alkyl, —NH2 or —COCH3;
- and
- wherein R6 is represented by
Dependencies are inferred from the claim text.